Annual Accounts Payable
$1.17 M
-$1.38 M-54.17%
31 December 2023
Summary:
Inozyme Pharma annual accounts payable is currently $1.17 million, with the most recent change of -$1.38 million (-54.17%) on 31 December 2023. During the last 3 years, it has fallen by -$1.90 million (-62.01%). INZY annual accounts payable is now -62.01% below its all-time high of $3.07 million, reached on 31 December 2020.INZY Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$2.21 M
-$1.32 M-37.34%
30 September 2024
Summary:
Inozyme Pharma quarterly accounts payable is currently $2.21 million, with the most recent change of -$1.32 million (-37.34%) on 30 September 2024. Over the past year, it has increased by +$204.00 thousand (+10.17%). INZY quarterly accounts payable is now -39.70% below its all-time high of $3.67 million, reached on 30 September 2020.INZY Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INZY Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -54.2% | +10.2% |
| 3 y3 years | -62.0% | +253.0% |
| 5 y5 years | +18.5% | - |
INZY Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -62.0% | at low | -37.3% | +253.0% |
| 5 y | 5 years | -62.0% | +29.4% | -39.7% | +253.0% |
| alltime | all time | -62.0% | +29.4% | -39.7% | +253.0% |
Inozyme Pharma Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $2.21 M(-37.3%) |
| June 2024 | - | $3.53 M(+62.8%) |
| Mar 2024 | - | $2.17 M(+85.8%) |
| Dec 2023 | $1.17 M(-54.2%) | $1.17 M(-41.9%) |
| Sept 2023 | - | $2.01 M(-0.4%) |
| June 2023 | - | $2.01 M(+11.0%) |
| Mar 2023 | - | $1.81 M(-28.7%) |
| Dec 2022 | $2.54 M | $2.54 M(+82.9%) |
| Sept 2022 | - | $1.39 M(+3.9%) |
| June 2022 | - | $1.34 M(-39.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $2.20 M(-8.1%) |
| Dec 2021 | $2.39 M(-22.0%) | $2.39 M(+282.4%) |
| Sept 2021 | - | $626.00 K(-21.4%) |
| June 2021 | - | $796.00 K(-53.4%) |
| Mar 2021 | - | $1.71 M(-44.3%) |
| Dec 2020 | $3.07 M(+240.6%) | $3.07 M(-16.3%) |
| Sept 2020 | - | $3.67 M(+162.0%) |
| June 2020 | - | $1.40 M(-10.8%) |
| Mar 2020 | - | $1.57 M(+74.1%) |
| Dec 2019 | $901.00 K(-8.4%) | $901.00 K |
| Dec 2018 | $984.00 K | - |
FAQ
- What is Inozyme Pharma annual accounts payable?
- What is the all time high annual accounts payable for Inozyme Pharma?
- What is Inozyme Pharma annual accounts payable year-on-year change?
- What is Inozyme Pharma quarterly accounts payable?
- What is the all time high quarterly accounts payable for Inozyme Pharma?
- What is Inozyme Pharma quarterly accounts payable year-on-year change?
What is Inozyme Pharma annual accounts payable?
The current annual accounts payable of INZY is $1.17 M
What is the all time high annual accounts payable for Inozyme Pharma?
Inozyme Pharma all-time high annual accounts payable is $3.07 M
What is Inozyme Pharma annual accounts payable year-on-year change?
Over the past year, INZY annual accounts payable has changed by -$1.38 M (-54.17%)
What is Inozyme Pharma quarterly accounts payable?
The current quarterly accounts payable of INZY is $2.21 M
What is the all time high quarterly accounts payable for Inozyme Pharma?
Inozyme Pharma all-time high quarterly accounts payable is $3.67 M
What is Inozyme Pharma quarterly accounts payable year-on-year change?
Over the past year, INZY quarterly accounts payable has changed by +$204.00 K (+10.17%)